shares in this article
On February 7th, 2023, Idorsia will open the books for the quarter that ended on December 31st, 2022.
The forecasts of 5 analysts amount to an average EPS of CHF -1.303 per share for the most recent quarter. A year earlier, Idorsia had posted a loss per share of CHF -1.320.
The estimates of 5 analysts regarding sales for the past quarter amount to an average of CHF 32.9 million – an increase of 557.60 percent compared to the same quarter last year, in which Idorsia was able to generate CHF 5.0 million.
For the fiscal year that just ended, 13 analysts expect an average loss per share of CHF -4.654 compared to CHF -3.410 in the previous fiscal year. 14 analysts estimate sales at an average of CHF 77.0 million, compared to CHF 35.0 million previously generated.
Editorial office finanzen.net
Leverage must be between 2 and 20
More news about Idorsia AG
Image Sources: Idorsia Pharmaceuticals Ltd